RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 92 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,000 | 0.0% | 251 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | 0.0% | 251 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -40.0% | 251 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 251 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -99.7% | 251 | -99.7% | 0.00% | -100.0% |
| Q2 2020 | $1,926,000 | +217.3% | 86,359 | +116.7% | 0.01% | +200.0% |
| Q1 2020 | $607,000 | – | 39,859 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 735,000 | $13,112,400 | 3.93% |
| NEA Management Company, LLC | 2,909,956 | $51,913,615 | 3.59% |
| Frazier Life Sciences Management, L.P. | 2,164,739 | $38,618,944 | 2.80% |
| RA Capital Management | 5,516,067 | $98,406,635 | 2.23% |
| Samsara BioCapital, LLC | 345,293 | $6,160,027 | 1.27% |
| Rock Springs Capital Management LP | 1,597,123 | $28,492,674 | 0.68% |
| Baker Brothers Advisors | 6,498,267 | $115,929,083 | 0.63% |
| HighVista Strategies LLC | 35,478 | $632,928 | 0.52% |
| Nan Fung Group Holdings Ltd | 32,520 | $580,157 | 0.40% |
| GREAT POINT PARTNERS LLC | 97,544 | $1,740,185 | 0.34% |